Atosiban

TypeName:

Business Offer

Request Date:

2017/06/23

Country:

United States

Summary:

(Deamino-Cys1,D-Tyr(Et)2,Thr4,Orn8)-Oxytocin; Antocin; Tractocile; RWJ 22164; RWJ22164; RWJ-22164; ORF 22164; ORF22164; ORF-22164; deTVT; dE-TVT; Atosibanum ; Atosiban; d(TVT); CAP 476

Description:

Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban is indicated to delay imminent pre-term birth in pregnant adult women. Atosiban is useful in improving the pregnancy outcome of in vitro fertilization-embryo transfer (IVF-ET) in patients with repeated implantation failure (RIF). The pregnancy rate improved from zero to 43.7%.http://www.creative-peptides.com/product/atosiban-item-10-101-05-14.html

Advantages:

[RequestAdvantages]

Comments:

[RequestComments]

RequestId:

267

Name:

Cathy Miller

Telphone:

Email:

[email protected]